News & Events

NEWS
Press-Release
September 28, 2017
Computer model showed an optimal anti-amyloid treatment
Moscow, Russia, September 28, 2017. One must activate amyloid degradation as soon as possible to prevent the appearance of the protein plaques in brain under Alzheimer’s conditions. This conclusion was reached by scientists from the biotechnology company InSysBio, who created the first computer model of the disease. The final part of the work has been recently published in CPT: Pharmacometrics & Systems Pharmacology.
LEARN MORE
NEWS
Press-Release
July 25, 2017
InSysBio LLC Announce Renewal of Agreement with ASTEX Pharmaceuticals Inc.
Moscow, Russia, July 25, 2017 – InSysBio LLC (www.insysbio.ru), one of the pioneers in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, announced today a renewal of multi-year Master Service Agreement with ASTEX Pharmaceuticals, Inc.
LEARN MORE
September 2026
MoTuWeThFrSaSu
 
1
2
3
4
5
6
7
8
9
1. 09 Sep 2026 17:40 InSysBio to take part in ACoP 2026 InSysBio announces its participation in ACoP 2026 which is to be held from October 11-14, 2026 at the Gaylord National Resort & Convention Center, Oxon Hill, Maryland, USA. InSysBio team is going to present its QSP modeling services & software to optimize drug development at the Booth #11 and 6 posters
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
    
Upcoming Events
11.10
InSysBio to take part in ACoP 2026
Tags